In addition, a cerebrospinal fluid (CSF) proteomics study defined three AD subtypes according to their biochemical profile (hyperplasticity and increased β-Secretase 1 (BACE1) levels, innate immune activation, and blood–brain barrier dysfunction with low BACE1 levels) [6]. This evidence concerns the gene BACE1 and Alzheimer disease.